Search Browse Earnings

enGene Holdings Inc.

Nasdaq:ENGNNasdaq:ENGNW

Biological Products, (No Diagnostic Substances)·SAINT-LAURENT, A8

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

enGene Holdings Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$62.0M

FY 2025

Net Income

-$55.1M

FY 2025

EPS (Diluted)

$1.46

FY 2025

Stock Price

$8.66

-0.7%

2026-03-06

52W Range

$2.65 – $12.25

P/E Ratio

5.9x

Market Cap

$580.1M

Cash

$173.0M

FY 2025

Total Debt

$23.2M

FY 2025

Net Cash

$149.8M

FY 2025

Enterprise Value

$430.3M

Debt / EBITDA

2.4x

FY 2025

EV / EBITDA

-6.9x

Employees

—